Canada gets the pot headlines, but a U.S. market is catching up

Bloomberg News
November 11, 2018 at 9:48PM
In this Wednesday, Oct. 17, 2018 photo patient service associate Nelson Rivera III, left, sells medical cannabis products to Victoria Silva, of Amherst, Mass., right, at a New England Treatment Access medical marijuana dispensary, in Northampton, Mass. Within days perhaps, the medical marijuana dispensary in Northampton expects to receive the final go-ahead to throw its doors open to anyone 21 or older who wants to purchase cannabis products ranging from flower to edibles, creams and even suppos
In this Wednesday, Oct. 17, 2018 photo patient service associate Nelson Rivera III, left, sells medical cannabis products to Victoria Silva, of Amherst, Mass., right, at a New England Treatment Access medical marijuana dispensary, in Northampton, Mass. Within days perhaps, the medical marijuana dispensary in Northampton expects to receive the final go-ahead to throw its doors open to anyone 21 or older who wants to purchase cannabis products ranging from flower to edibles, creams and even suppositories. (AP Photo/Steven Senne) (Mike Nelson — Associated Press/The Minnesota Star Tribune)

Canada has a challenger to its status as the pot-stock capital of the world — the scrappy over-the-counter market in the United States.

There are now 136 cannabis-related securities on OTC Markets Group Inc.'s main and venture market. That compares with 144 companies on Canadian exchanges.

With marijuana illegal at the federal level in the U.S., the big exchanges like the NYSE and the Nasdaq only allow listings from companies that don't have American operations, including five Canadian producers. Rules on the New York-based OTC markets are less stringent and allow companies on qualified foreign exchanges to trade without registering with the Securities and Exchange Commission. Fees are also lower.

"The exchanges are very risk averse. They're old, staid institutions," Jason Paltrowitz, executive vice president of corporate services at OTC Markets, said. "We want to be the market for entrepreneurs."

The OTC's growing presence in the cannabis space is aided by a partnership with the Canadian Securities Exchange, jokingly referred to as the Cannabis Securities Exchange for the zeal with which it's embraced the industry. Formerly focused on junior miners and energy companies, pot stocks now make up about a quarter of the CSE's 450 listings. Of those, 116 trade on OTC markets, including 13 pot stocks on the top-tier OTCQX.

"For the companies that aren't in the billion-plus market cap range, the benefit from being listed on an exchange is minimal to nonexistent," Paltrowitz said.

Canadian exchanges have a head start in heft. But the 136 cannabis companies on the OTC markets are worth $16 billion, ranging in size from MedMen Enterprises Inc., which is worth $2.6 billion, to penny stocks like Global Hemp Group Inc., with a market value of about $16.3 million.

Cross-listing allows cannabis companies to access U.S. investors while continuing to tap capital markets in Canada, which legalized recreational pot last month and has led deal-making and financing in the global marijuana industry. This has aided growth at U.S.-focused pot companies like MedMen.

The CSE listing provided early access to capital and a knowledgeable pool of investors, while OTCQX "provides a number of complementary benefits including an efficient trading platform, increased liquidity and better access to a growing U.S. investor base," MedMen spokeswoman Briana Chester said in an e-mail.

about the writers

about the writers

Kristine Owram

Nick Baker

More from Business

See More
card image
Jeremy Olson/The Minnesota Star Tribune

The funding, temporarily preserved by a judge’s order, supported nurses and others providing rural health access as well as efforts to prepare for public health emergencies.

card image
A logo sign outside of a facility occupied by Cargill Animal Nutrition in Little Chute, Wis., on June 24, 2018.